Literature DB >> 21604042

The optimal lipid formulation in enteral feeding in critical illness: clinical update and review of the literature.

Craig Munroe1, David Frantz, Robert G Martindale, Stephen A McClave.   

Abstract

Suitable and timely early enteral nutrition is paramount to providing optimal patient care for the critically ill. Lipids serve many essential roles throughout the human body, and are important components of most enteral formulations. This paper reviews lipid structure, function, and optimal utility for this macronutrient in enteral feeds. The use of omega-3 fatty acids has become common in critical care formulations, and their clinical efficacy is outlined separately. Available evidence is reviewed, and future directions are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604042     DOI: 10.1007/s11894-011-0203-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  42 in total

Review 1.  Complications of enteral access.

Authors:  Stephen A McClave; Wei-Kuo Chang
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

Review 2.  Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary.

Authors:  Robert G Martindale; Stephen A McClave; Vincent W Vanek; Mary McCarthy; Pamela Roberts; Beth Taylor; Juan B Ochoa; Lena Napolitano; Gail Cresci
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

3.  Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects.

Authors:  Thomas-Thi Pluess; Daniel Hayoz; Mette M Berger; Luc Tappy; Jean-Pierre Revelly; Burkhard Michaeli; Yvon A Carpentier; René L Chioléro
Journal:  Intensive Care Med       Date:  2007-03-22       Impact factor: 17.440

Review 4.  Essential fats for future health. Proceedings of the 9th Unilever Nutrition Symposium, 26-27 May 2010.

Authors:  P C Calder; A D Dangour; C Diekman; A Eilander; B Koletzko; G W Meijer; D Mozaffarian; H Niinikoski; S J M Osendarp; P Pietinen; J Schuit; R Uauy
Journal:  Eur J Clin Nutr       Date:  2010-12       Impact factor: 4.016

Review 5.  Essential fatty acids in health and chronic disease.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

6.  Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.

Authors:  J E Gadek; S J DeMichele; M D Karlstad; E R Pacht; M Donahoe; T E Albertson; C Van Hoozen; A K Wennberg; J L Nelson; M Noursalehi
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

Review 7.  Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils.

Authors:  M Massaro; E Scoditti; M A Carluccio; M C Campana; R De Caterina
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2010-02-25       Impact factor: 1.770

Review 8.  New lipids in enteral feeding.

Authors:  Claude C Roy; Lise Bouthillier; Ernest Seidman; Emile Levy
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-03       Impact factor: 4.294

Review 9.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective.

Authors:  Pierre Singer; Haim Shapiro; Miryam Theilla; Ronit Anbar; Joelle Singer; Jonathan Cohen
Journal:  Intensive Care Med       Date:  2008-05-07       Impact factor: 17.440

Review 10.  Fish oil in critical illness.

Authors:  Konstantin Mayer; Werner Seeger
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-03       Impact factor: 4.294

View more
  1 in total

1.  Prescribing practice and evaluation of appropriateness of enteral nutrition in a university teaching hospital.

Authors:  Xiu-Ping Zhu; Ling-Ling Zhu; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2013-02-07       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.